Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,079,115
New position
Shares Held
13,858
first reported quarter
Ownership
0.010%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#257
of 593 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Fieldview Capital Management, LLC holds $4,957,931 across 8 Diagnostics & Research names. GH ranks #1 (41.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
This page
|
13,858 | $2,079,115 | |
| 2 | NTRA |
Natera, Inc.
|
1,756 | $476,666 | |
| 3 | WAT |
Waters Corp /De/
|
1,224 | $459,048 | |
| 4 | DHR |
Danaher Corp /De/
|
2,315 | $440,961 | |
| 5 | SHC |
Sotera Health Co
|
24,465 | $434,253 | |
| 6 | LH |
Labcorp Holdings Inc.
|
1,407 | $393,960 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
1,944 | $375,619 | |
| 8 | TMO |
Thermo Fisher Scientific Inc.
|
595 | $298,309 |
All Filings in GH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,079,115 | 13,858 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||